Angiotensin receptor blockers significantly reduce hemoglobin level in patients with type 2 diabetes mellitus not suffered chronic cardiac failure and chronic kidney disease

Anemia due to angiotensin receptor blocker (ARB) therapy has been previously reported in patients with diabetes mellitus with glomerular filtration rates of

Saved in:
Bibliographic Details
Published in:Endocrine Journal 2021, Vol.68(4), pp.503-507
Main Authors: Watanabe, Takuya, Temma, Yuichi, Okada, Junichi, Yamada, Eijiro, Ishida, Emi, Horiguchi, Kazuhiko, Saito, Tsugumichi, Okada, Kazuya, Takamizawa, Tetsuya, Nakajima, Yasuyo, Ozawa, Atsushi, Okada, Shuichi, Horigome, Mitsuaki, Yamada, Masanobu
Format: Article
Language:English
Subjects:
Angiotensin
Angiotensin receptor blocker
Diabetes
Diabetes mellitus (non-insulin dependent)
Epidermal growth factor receptors
Glucose transporter
Glycated hemoglobin
Heart diseases
Hemoglobin
Kidney diseases
Renal failure
Type 2 diabetes mellitus
α-Glucosidase
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anemia due to angiotensin receptor blocker (ARB) therapy has been previously reported in patients with diabetes mellitus with glomerular filtration rates of
ISSN:0918-8959
1348-4540
DOI:10.1507/endocrj.EJ20-0773